HOP-2A - Intratesticular Hormone Levels
NCT00756561 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2016-06-13
Summary
The purpose of this investigational study is to find out what hormones are present in healthy male testicles using fine needle aspiration.
Conditions
- Healthy
- Male Infertility
- Prostate Disease
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
John K Amory, MD, MPH · University of Washington
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-09-30
- Primary Completion
- 2009-01-31
- Completion
- 2009-12-31
Countries
- United States
Study Locations
More Related Trials
-
Oral Testosterone for the Treatment of Hypogonadism
NCT01717768 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone
NCT00161421 ·Status: COMPLETED ·Phase: PHASE2
-
Symptoms and Clinical Signs of Hypogonadism in Testicular Cancer Survivors
NCT02240966 ·Status: COMPLETED
-
Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury.
NCT00223860 ·Status: COMPLETED ·Phase: NA
-
Opioid Antagonism in Hypogonadotropic Hypogonadism
NCT04975334 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose, Dose-Ranging Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men
NCT02754687 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Dihydrotestosterone (DHT) on Prostate Tissue [Short Title: DHT-3]
NCT00490022 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
7 Tesla MRI Neuroimaging in Testicular Cancer Patients With Hypogonadism and on Androgen Replacement Therapy
NCT06191575 ·Status: SUSPENDED
-
A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937)
NCT01709331 ·Status: COMPLETED ·Phase: PHASE3
-
Calciotropic Effects After HCG Stimulation Test
NCT03254641 ·Status: COMPLETED
-
Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men
NCT00431197 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males
NCT00372008 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men
NCT00467870 ·Status: COMPLETED ·Phase: PHASE3
-
Hypogonadism in Young Men With Type 2 Diabetes
NCT01155518 ·Status: TERMINATED ·Phase: PHASE2
-
Testosterone Undecanoate and Quality of Life of Men and Spouses
NCT01758029 ·Status: UNKNOWN
-
Testosterone-Dependent Effects on Protein Biomarkers From Healthy Males
NCT03541395 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Pharmacokinetics and Safety of Testosterone
NCT01370369 ·Status: COMPLETED ·Phase: PHASE2
-
Testosterone Replacement for Male Opioid Agonist Maintained Patients
NCT01873989 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Transdermal Testosterone for Poor Responder Patients Undergoing Controlled Ovarian Stimulation Prior to IVF
NCT03078569 ·Status: UNKNOWN ·Phase: PHASE4
-
Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17
NCT06312761 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue
NCT00490555 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Oral Testosterone for the Treatment of Hypogonadism in Males
NCT02222558 ·Status: COMPLETED ·Phase: PHASE2
-
Testosterone Treatment in a Patient With 17β-hydroxysteroid Dehydrogenase Type 3 Deficiency: an N-of-1 Study
NCT04831099 ·Status: UNKNOWN ·Phase: PHASE3
-
ITT4 Intratesticular Hormonal Milieu in Man (ITT4)
NCT01215292 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH)
NCT03118479 ·Status: TERMINATED ·Phase: PHASE1